About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Immunotherapy to Treat Advanced Prostate Cancer

NCT00861614·158 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bristol-Myers Squibb

Age

18–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Advanced prostate cancer
At least 1 bone metastasis
Testosterone \< 50 ng/dl
Prior treatment with docetaxel

You may not be if

Brain metastasis
Autoimmune disease
Known HIV, Hep B, or Hep C infection
More than 2 prior systemic anticancer regimens for prostate cancer
Prior treatment on BMS CA180227 for prostate cancer

The record

StatusCompleted

PhasePhase 3

Taking part988

StartedMay 2009

UpdatedSep 30, 2016

Conditions

Prostate Cancer

Where158

Southern Cancer Center
Mobile, Alabama, United States
Alaska Clinical Research Center, Llc
Anchorage, Alaska, United States
Arizona Clinical Research Center, Inc.
Tucson, Arizona, United States

Clareo Health | Study of Immunotherapy to Treat Advanced Prostate Cancer